Lawrenceville, March 24, 2026 — A major milestone in Georgia’s growing life sciences sector was announced Tuesday as UCB revealed plans to invest $2 billion in a new manufacturing facility in Gwinnett County—the largest economic development deal in the county’s history.
The Brussels-based biopharmaceutical company will establish its first U.S. biologics manufacturing campus at the Rowen Foundation’s 2,000-acre innovation hub. The state-of-the-art facility is expected to create more than 330 high-quality jobs and serve as a central hub for the company’s U.S. manufacturing operations.
Spanning roughly the size of eight football fields, the advanced campus will incorporate cutting-edge technologies such as artificial intelligence, robotics, and automation, reinforcing Georgia’s emergence as a national leader in life sciences and advanced manufacturing.
Georgia officials, including Brian Kemp, emphasized the significance of the investment, noting it as one of the largest in state history and a major step in positioning the region as a global innovation hub.
The project is also expected to generate an estimated $5 billion in long-term economic impact, further strengthening metro Atlanta’s role in biotechnology, research, and medical innovation.
For Gwinnett County—one of the most diverse communities in the Southeast—the investment signals both economic growth and increased opportunities in high-skilled industries, aligning with broader efforts to attract global companies and talent to the region.
